Detalles de la búsqueda
1.
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk.
Hum Genomics
; 18(1): 12, 2024 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38308339
2.
Immune checkpoint inhibitors plus chemotherapy in first-line endometrial cancer treatment: Still the era of microsatellites?
BJOG
; 131(8): 1157-1159, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164107
3.
Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective.
Semin Cancer Biol
; 86(Pt 3): 997-1007, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34838957
4.
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM.
Int J Cancer
; 153(1): 153-163, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883420
5.
Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study.
Mol Med
; 29(1): 14, 2023 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717774
6.
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians.
Biol Res
; 56(1): 46, 2023 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37574541
7.
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.
Int J Cancer
; 151(3): 473-480, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35429341
8.
Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis.
Int J Gynecol Cancer
; 2022 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36229080
9.
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction.
J Med Genet
; 58(6): 369-377, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591343
10.
The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy.
Int J Mol Sci
; 23(7)2022 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35409229
11.
Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives.
Int J Mol Sci
; 23(2)2022 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35055006
12.
Immunohistochemistry with 3 different clones in anaplastic lymphoma kinase fluorescence in situ hybridization positive non-small-cell lung cancer with thymidylate synthase expression analysis: a multicentre, retrospective, Italian study.
Pathologica
; 114(4): 278-287, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083243
13.
Appropriateness of trifluridine/tipiracil in the clinical practice of third-line therapy in metastatic colorectal cancer.
Future Oncol
; 17(14): 1749-1759, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33464133
14.
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018).
BMC Cancer
; 20(1): 822, 2020 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32867715
15.
Intestinal adenosquamous carcinoma with a synchronous skin metastasis: a immunohistochemical and molecular analysis.
Int J Colorectal Dis
; 35(2): 337-341, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31823050
16.
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Oncologist
; 24(2): 185-192, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190299
17.
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
Oncologist
; 24(3): 385-393, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30606884
18.
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients.
Pharmacogenomics J
; 19(6): 556-563, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30723313
19.
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
BMC Cancer
; 19(1): 283, 2019 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30922323
20.
Methylation Density Pattern of KEAP1 Gene in Lung Cancer Cell Lines Detected by Quantitative Methylation Specific PCR and Pyrosequencing.
Int J Mol Sci
; 20(11)2019 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-31159323